N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide

C65H70F8N12O13 — CID 160795597

IUPACN-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide
SMILESC#CCCC(=O)N(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)OC.C=C(C)C(=O)N(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)OC.COC(C)C(=O)N(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)OC.CON(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)C(=O)C1CC1
InChIInChI=1S/C17H17F2N3O3.C16H19F2N3O4.2C16H17F2N3O3/c1-4-5-6-14(23)22(24-3)11-12-7-9-13(10-8-12)15-20-16(25-21-15)17(2,18)19;1-10(23-3)14(22)21(24-4)9-11-5-7-12(8-6-11)13-19-15(25-20-13)16(2,17)18;1-16(17,18)15-19-13(20-24-15)11-5-3-10(4-6-11)9-21(23-2)14(22)12-7-8-12;1-10(2)14(22)21(23-4)9-11-5-7-12(8-6-11)13-19-15(24-20-13)16(3,17)18/h1,7-10H,5-6,11H2,2-3H3;5-8,10H,9H2,1-4H3;3-6,12H,7-9H2,1-2H3;5-8H,1,9H2,2-4H3
InChIKeySCKANTCBAZCXNF-UHFFFAOYSA-N
MW1379.33 g/mol
LogP12.39
Rot. Bonds26

About N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide

N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide (PubChem CID 160795597) has the molecular formula C65H70F8N12O13 and a molecular weight of 1379.33 g/mol. Its IUPAC name is N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide.

Molecular Properties

Compound NameN-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide
PubChem CID160795597
Molecular FormulaC65H70F8N12O13
Molecular Weight1379.33 g/mol
Exact Mass1378.51
IUPAC NameN-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide
SMILESC#CCCC(=O)N(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)OC.C=C(C)C(=O)N(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)OC.COC(C)C(=O)N(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)OC.CON(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)C(=O)C1CC1
InChIInChI=1S/C17H17F2N3O3.C16H19F2N3O4.2C16H17F2N3O3/c1-4-5-6-14(23)22(24-3)11-12-7-9-13(10-8-12)15-20-16(25-21-15)17(2,18)19;1-10(23-3)14(22)21(24-4)9-11-5-7-12(8-6-11)13-19-15(25-20-13)16(2,17)18;1-16(17,18)15-19-13(20-24-15)11-5-3-10(4-6-11)9-21(23-2)14(22)12-7-8-12;1-10(2)14(22)21(23-4)9-11-5-7-12(8-6-11)13-19-15(24-20-13)16(3,17)18/h1,7-10H,5-6,11H2,2-3H3;5-8,10H,9H2,1-4H3;3-6,12H,7-9H2,1-2H3;5-8H,1,9H2,2-4H3
InChIKeySCKANTCBAZCXNF-UHFFFAOYSA-N
XLogP12.39
TPSA283.07 Ų
H-Bond Donors
H-Bond Acceptors21
Rotatable Bonds26
Heavy Atoms98
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001379.33
LogP ≤ 512.39
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide?
The IUPAC name of N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide (CID 160795597) is N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide.
What is the SMILES notation for N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide?
The canonical SMILES for N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide is C#CCCC(=O)N(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)OC.C=C(C)C(=O)N(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)OC.COC(C)C(=O)N(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)OC.CON(Cc1ccc(-c2noc(C(C)(F)F)n2)cc1)C(=O)C1CC1.
What is the InChIKey of N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide?
The InChIKey is SCKANTCBAZCXNF-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H17F2N3O3.C16H19F2N3O4.2C16H17F2N3O3/c1-4-5-6-14(23)22(24-3)11-12-7-9-13(10-8-12)15-20-16(25-21-15)17(2,18)19;1-10(23-3)14(22)21(24-4)9-11-5-7-12(8-6-11)13-19-15(25-20-13)16(2,17)18;1-16(17,18)15-19-13(20-24-15)11-5-3-10(4-6-11)9-21(23-2)14(22)12-7-8-12;1-10(2)14(22)21(23-4)9-11-5-7-12(8-6-11)13-19-15(24-20-13)16(3,17)18/h1,7-10H,5-6,11H2,2-3H3;5-8,10H,9H2,1-4H3;3-6,12H,7-9H2,1-2H3;5-8H,1,9H2,2-4H3.
What are the key properties of N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide?
N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide has a molecular weight of 1379.33 g/mol, XLogP of 12.39, 26 rotatable bonds, 0 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N,2-dimethoxypropanamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropanecarboxamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxy-2-methylprop-2-enamide;N-[[4-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxypent-4-ynamide is sourced from PubChem (CID 160795597), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).